The management team includes entrepreneurs with successful IPO/acquisition exits, world class scientists, renowned scientific advisors, and a board with experienced pharma, technology and healthcare executives.
Eric Hunter
Eric serves as the Company’s Chief Executive Officer. Mr. Hunter is author or co- author on over 130 patents. He has extensive experience in the founding and managing a range of businesses in the high technology, manufacturing and medical device industries. Two of these companies, Cree Inc. and Charles & Colvard LLC, are publicly traded on Nasdaq. Mr. Hunter also co-founded a medical device company, Quill Medical, which was sold to Angiotech Pharmaceuticals, Inc. for $200 million in 2005 and an eye care company, Corinthian Ophthalmic, Inc., that was sold to Eyenovia, Inc. in 2014.
Rich Gimigliano
Rich serves as Pneuma’s Chief Financial Officer and is a senior financial executive with outstanding analytical skills, proven leadership and a record of building successful businesses. He has extensive investment banking experience across equity, debt and advisory assignments. His experience includes positions as managing director at Viant Capital, managing director investment banking at Merriman Capital, partner at ThinkEquity LLC and at Thomas Weisel Partners, and a managing director at Montgomery Securities, Lehman Brothers and Credit Suisse First Boston.
Jack Hebrank, PhD
Jack serves as Pneuma’s Chief Scientific Officer. With a PhD in Mechanical and Electrical Engineering from Duke University, Dr. Hebrank taught fluid mechanics for 18 years at North Carolina State University. He also has had an impressive career as Director of Technical Development for Embrex from 1997-2007. After Embrex was acquired by Pfizer, Dr. Hebrank served as Senior Principal Scientist for Pfizer from 2007-2015.
Jack Hebrank, PhD
Serves as Director of High Volume Manufacturing Team. Mr. Li has an impressive manufacturing career working as a Senior Manager at Foxconn and brings to Pneuma 20+ years of high volume manufacturing experience in world-leading products.
Huey Wang
Huey serves as Pneuma’s General Manager for Asia. Mr. Wang has an MBA from UC Berkeley and a MSEE in Electrical and Computer Engineering from the University of Wisconsin. Prior to joining Pneuma, he was Senior Director of Technical Marketing at Macronix, Director of IP Portfolio Marketing at TSMC, and Corporate Venture Fund Manager at Mosel Vitelic.
J. Sid Clements, PhD
Sid serves as Pneuma’s Droplet Physics Advisor and is a world expert in aerosolized droplet physics and electrostatistics. A former Fulbright Fellowship recipient, Dr. Clements was a Faculty Fellow in NASA’s electrostatics and advanced materials laboratory. Dr. Clements is a Professor (Physics Department) at Appalachian State University, a consultant for Boeing, and Exxon Fellow in the IEEE.
Walt Robb, PhD.
The former Senior VP of General Electric, serves as the Chairman of the Board and is a liaison to the medical device industry. In his career at GE, Dr. Robb led GE Medical (now GE Healthcare) for 13 years and GE Corporate R&D for 6 years. He grew GE Medical from 1,000 to 10,000 employees. Dr. Robb received the National Medal of Technology from President Clinton for his leadership in the CT and MR imaging industry.
Jay Morgan
The former Chief Operating Officer for Research Operations at Merck Consumer Health, serves as a Director. At Merck, he led global product development and founded a Human Centered Design team as Vice President of Innovation. Further, Mr. Morgan has also led innovation for Bayer Consumer Health as VP Global Innovation & Design. As a founding member of the non-profit Memphis Innovation Bootcamp, Mr. Morgan is committed to helping equip community leaders, businesses and educators realize a better future through innovation best practices.
Douglas Stoner
Special Council for Hoffman Warnick LLC, a leading Boston-based intellectual property law office, serves as a Director. Much of Mr. Stoner’s practice is devoted to licensing matters and cooperative research agreements directed toward maximizing the impact of IP on profits. Prior to joining Hoffman Warnick LLC, he enjoyed a 28-year career with General Electric where he served as chief IP Counsel at GE Medical Systems for 14 years and as General Counsel at GE Corporate Research and Development for 9 years. Mr. Stoner directed GE’s IP departments in the US, France, Japan and India.
J. Knox Singleton
Until his retirement in July 2018, Mr. Singleton, served for 35 years as the CEO of Inova Health System, the largest employer in Northern Virginia, where he oversaw the evolution of Inova from a three hospital, $500 million enterprise with 1,000 employees to a $3.5 billion healthcare system with five hospitals, a health insurance company and over a hundred ambulatory service locations and 17,000 employees. Mr. Singleton has received numerous awards during his career in recognition of his leadership in the field of health care.